Cirugía de reducción pulmonar: 5 años después.

Same author

Spinal manifestations of CLN1 disease start during the early postnatal period.

Neuropathology and applied neurobiology·2020

Same author

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

Scientific reports·2019

Same author

Desmopressin stimulation testing: Response to intravenous and intranasal forms.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Same author

Serum proteomic profiles of depressive subtypes.

Translational psychiatry·2016

Same author

Serum biomarkers predictive of depressive episodes in panic disorder.

Journal of psychiatric research·2015

Same author

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Translational psychiatry·2015

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Cirugía de reducción pulmonar: 5 años después.

Videos de Conceptos Relacionados

Spinal manifestations of CLN1 disease start during the early postnatal period.

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

Desmopressin stimulation testing: Response to intravenous and intranasal forms.

Serum proteomic profiles of depressive subtypes.

Serum biomarkers predictive of depressive episodes in panic disorder.

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Cirugía de reducción pulmonar: 5 años después.

Videos de Conceptos Relacionados

Artículos Relacionados

Spinal manifestations of CLN1 disease start during the early postnatal period.

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

Desmopressin stimulation testing: Response to intravenous and intranasal forms.

Serum proteomic profiles of depressive subtypes.

Serum biomarkers predictive of depressive episodes in panic disorder.

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.